SG Americas Securities’s iRadimed IRMD Stock Holding History

SG Americas Securities’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$899K	Sell	9,408 -64,153	-87%	-$5.84M	﹤0.01%	1949
2026 Q1	$7.08M	Buy	73,561 +3,170	+5%	+$317K	0.01%	910
2025 Q4	$6.85M	Buy	70,391 +33,072	+89%	+$2.84M	0.01%	946
2025 Q3	$2.66M	Buy	37,319 +803	+2%	+$53.5K	0.01%	804
2025 Q2	$2.18M	Buy	36,516 +29,339	+409%	+$1.61M	0.01%	733
2025 Q1	$377K	Buy	7,177 +582	+9%	+$32.7K	﹤0.01%	2012
2024 Q4	$363K	Buy	6,595 +3,664	+125%	+$193K	﹤0.01%	1630
2024 Q3	$147K	Buy	+2,931	New	+$135K	﹤0.01%	2754
2023 Q2	–	Sell	-2,975	Closed	-$117K	–	2713
2023 Q1	$117K	Buy	+2,975	New	+$108K	﹤0.01%	2813

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities's IRMD Position: Q2 2026 in Review

SG Americas Securities reduced its iRadimed (IRMD) stake by 87% in Q2 2026, selling an estimated $5.84M and leaving 9,408 shares worth $899K. The position accounts for ﹤0.01% of the portfolio, ranked #1949.

SG Americas Securities first reported a position in IRMD in Q1 2023 and has held it in 9 quarters since. The position peaked at $7.08M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

SG Americas Securities held 9,408 shares of iRadimed worth $899K as of Q2 2026.
SG Americas Securities sold 64,153 iRadimed shares in Q2 2026, an estimated $5.84M.
iRadimed made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1949 holding.
SG Americas Securities first reported a position in iRadimed in Q1 2023 and has held it in 9 quarters since.
SG Americas Securities's iRadimed position peaked at $7.08M in Q1 2026.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.